Oscar Health (OSCR) Receivables (2020 - 2026)

Oscar Health (OSCR) has reported Receivables for 7 consecutive years, with $380.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables fell 18.34% year-over-year to $380.1 million; the trailing twelve-month figure through Jun 2026 stood at $380.1 million (down 18.34% YoY), and the FY2025 full-year result was $362.7 million, up 14.81% from the prior year.
• Receivables retreated to $380.1 million in Q2 2026 per OSCR's latest filing, from $587.0 million in the prior quarter.
• Across five years, Receivables topped out at $587.0 million in Q1 2026 and bottomed at $33.7 million in Q4 2022.
• Historically, Receivables has averaged $303.1 million across 5 years, with a median of $308.3 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Receivables soared 1103.57% in 2022, then fell 18.34% in 2026.
• Over 5 years, Receivables stood at $33.7 million in 2022, then surged by 497.24% to $201.3 million in 2023, then surged by 56.95% to $315.9 million in 2024, then advanced by 14.81% to $362.7 million in 2025, then increased by 4.79% to $380.1 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $380.1 million, $587.0 million, and $362.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.